Search results
Results from the WOW.Com Content Network
Therapeutic cloning would involve cloning cells from a human for use in medicine and transplants. It is an active area of research, and is in medical practice over the world. Two common methods of therapeutic cloning that are being researched are somatic-cell nuclear transfer and (more recently) pluripotent stem cell induction. Reproductive ...
It is used in both therapeutic and reproductive cloning. In 1996, Dolly the sheep became famous for being the first successful case of the reproductive cloning of a mammal. [1] In January 2018, a team of scientists in Shanghai announced the successful cloning of two female crab-eating macaques (named Zhong Zhong and Hua Hua) from foetal nuclei. [2]
Two commonly discussed types of theoretical human cloning are therapeutic cloning and reproductive cloning. Therapeutic cloning would involve cloning cells from a human for use in medicine and transplants, and is an active area of research, but is not in medical practice anywhere in the world, as of 2024.
The announcement fueled a heated debate on bioethics, despite Hwang and Moon emphasizing that their work focused solely on therapeutic purposes and strongly opposing reproductive cloning. More ...
Dolly Dolly (taxidermy) Other name(s) 6LLS (code name) Species Domestic sheep (Finn-Dorset) Sex Female Born (1996-07-05) 5 July 1996 Roslin Institute, Midlothian, Scotland Died 14 February 2003 (2003-02-14) (aged 6) Roslin Institute, Midlothian, Scotland Cause of death Euthanasia Resting place National Museum of Scotland (remains on display) Nation from United Kingdom (Scotland) Known for ...
Article 11 of UNESCO's Universal Declaration on the Human Genome and Human Rights asserts that the reproductive cloning of human beings is contrary to human dignity, [10] that a potential life represented by the embryo is destroyed when embryonic cells are used, [11] and there is a significant likelihood that cloned individuals would be ...
The gene chosen was a therapeutic protein to demonstrate the potential of such recombinant DNA technology combined with animal cloning. This could hopefully be used to produce pharmacological and therapeutic proteins to treat human diseases. The protein in question was the human blood clotting factor IX. [2]
Reproductive Sciences Medical Center; Stemagen Corporation; Development of Human cloned Blastocyst Following Somatic Cell Nuclear Transfer (SCNT) with Adult Fibroblasts by Andrew J. French, Cathrine A. Adams, Linda S. Anderson, John R. Kitchen, Marcus R. Hughes and Samuel H. Wood. Published in the online journal Stem Cells published by AlphaMed Press January 17, 2008.